Home » Topics » Conferences

Conferences
RSS

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Agent for atopic dermatitis reported by Terumo

March 20, 1997

Highly potent and selective ETA antagonist from Tanabe Seiyaku

March 20, 1997

Mitsui Toatsu reveals orally active antiplatelet agent

March 20, 1997

Hirosaki University researchers present novel class Ib antiarrhythmic

March 20, 1997

Grelan characterizes candidate for diabetic complications

March 20, 1997

Eisai discovers novel selective PDE I inhibitor

March 19, 1997

Antihyperalgesic effects of bradykinin B2 antagonist from Fujisawa

March 19, 1997

JT characterizes novel COX-2 inhibitor

March 19, 1997

Novel Na+/H+-exchange inhibitor from Fujisawa with cardioprotective effects

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...